Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives. This study compared the survival outcomes, local control rate, and laryngeal preservation rate of various treatment strategies in the treatment of T3 squamous cell carcinoma of the glottis using proportional meta-analyses. Methods. Twenty-five retrospective case-series studies were included in these analyses. Treatment strategies were classified as total laryngectomy (TL), open partial laryngectomy (PL), transoral laser microsurgery (TLM), chemo-radiation therapy (CRT), and radiation therapy (RT) alone. Results. The overall survival rate and disease-specific survival rate among laryngeal preservation treatments did not differ from the overall survival rate of TL. However, the local control rate was lower with RT than TL and PL, and laryngeal preservation rates of TLM and CRT were higher than RT alone. Conclusion. Consideration of preservation of laryngeal function is necessary when treating T3 glottic squamous cell carcinoma. PL, TLM, and, CRT are considered more appropriate initial laryngeal preservation strategies if available.
Abstract
Objectives. This study compared the survival outcomes, local control rate, and laryngeal preservation rate of various treatment strategies in the treatment of T3 squamous cell carcinoma of the glottis using proportional meta-analyses. Methods. Twenty-five retrospective case-series studies were included in these analyses. Treatment strategies were classified as total laryngectomy (TL), open partial laryngectomy (PL), transoral laser microsurgery (TLM), chemo-radiation therapy (CRT), and radiation therapy (RT) alone. Results. The overall survival rate and disease-specific survival rate among laryngeal preservation treatments did not differ from the overall survival rate of TL. However, the local control rate was lower with RT than TL and PL, and laryngeal preservation rates of TLM and CRT were higher than RT alone. Conclusion. Consideration of preservation of laryngeal function is necessary when treating T3 glottic squamous cell carcinoma. PL, TLM, and, CRT are considered more appropriate initial laryngeal preservation strategies if available.
참고문헌 (46)
- Hoffman HT, "Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival", Laryngoscope, 116(9), pp.1~13 (2006)
- Department of Veterans Affairs Laryngeal Cancer Study Group, "Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer", N Engl J Med, 324(24), pp.1685~1690 (1991)[DOI]
- Forastiere AA, "Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer", J Clin Oncol, 31(7), pp.845~852 (2013)[DOI]
- McNeil BJ, "Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer", N Engl J Med, 305(17), pp.982~987 (1981)[DOI]
- Fu X, "Efficacy comparison between total laryngectomy and nonsurgical organ-preservation modalities in treatment of advanced stage laryngeal cancer: a meta-analysis", Medicine (Baltimore), 95(14), pp.e3142~ (2016)[DOI]
- Forastiere AA, "Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer", N Engl J Med, 349(22), pp.2091~2098 (2003)[DOI]
- 안순현, "Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery", Clinical and Experimental Otorhinolaryngology, 10(1), pp.1~43 (2017), 대한이비인후과학회[DOI]
- Mantsopoulos K, "Primary surgical treatment of T3 glottic carcinoma: long-term results and decision-making aspects", Laryngoscope, 122(12), pp.2723~2727 (2012)[DOI]
- American Society of Clinical Oncology, "American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer", J Clin Oncol, 24(22), pp.3693~3704 (2006)[DOI]
- Canis M, "Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery", Head Neck, 36(5), pp.652~659 (2014)[DOI]
- Megwalu UC, "Survival outcomes in advanced laryngeal cancer", JAMA Otolaryngol Head Neck Surg, 140(9), pp.855~860 (2014)[DOI]
- Hartl DM, "Evidence-based review of treatment options for patients with glottic cancer", Head Neck, 33(11), pp.1638~1648 (2011)[DOI]
- Edge S, "AJCC cancer staging handbook" (2010), Springer
- Weller MD, "The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis", Clin Otolaryngol, 35(5), pp.364~372 (2010)[DOI]
- El Dib R, "An alternative approach to deal with the absence of clinical trials: a proportional meta-analysis of case series studies", Acta Cir Bras, 28(12), pp.870~876 (2013)[DOI]
- Luo XN, "Effectiveness of chemotherapy and radiotherapy for laryngeal preservation in advanced laryngeal cancer: a meta-analysis and systematic review", Radiol Med, 120(12), pp.1153~1169 (2015)[DOI]
- Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315(7109), pp.629~634 (1997)[DOI]
- Neyeloff JL, "Meta-analyses and forest plots using a Microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis", BMC Res Notes, 5, pp.52~ (2012)[DOI]
- Porter MJ, "Audit in the management of T3 fixed-cord laryngeal cancer", Am J Otolaryngol, 19(6), pp.360~364 (1998)[DOI]
- Kowalski LP, "Prognostic factors in T3,N0-1 glottic and transglottic carcinoma: a multifactorial study of 221 cases treated by surgery or radiotherapy", Arch Otolaryngol Head Neck Surg, 122(1), pp.77~82 (1996)[DOI]
- Foote RL, "Laryngectomy alone for T3 glottic cancer", Head Neck, 16(5), pp.406~412 (1994)[DOI]
- Simpson D, "A comparison of radiotherapy and surgery as primary treatment in the management of T3 N0 M0 glottic tumours", J Laryngol Otol, 107(10), pp.912~915 (1993)
- Woodhouse RJ, "Treatment of carcinoma of the vocal cord: a review of 20 years experience", Laryngoscope, 91(7), pp.1155~1162 (1981)
- Harwood AR, "Management of advanced glottic cancer: a 10 year review of the Toronto experience", Int J Radiat Oncol Biol Phys, 5(6), pp.899~904 (1979)[DOI]
- Nakayama M, "One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control?", Jpn J Clin Oncol, 45(8), pp.732~737 (2015)[DOI]
- Leszczynska M, "Attempt to improve functional outcomes in supracricoid laryngectomy in T2b and T3 glottic cancers", Eur Arch Otorhinolaryngol, 272(10), pp.2925~2931 (2015)[DOI]
- Day AT, "Management of primary T1-T4 glottic squamous cell carcinoma by transoral laser microsurgery", Laryngoscope, 127(3), pp.597~604 (2017)[DOI]
- Ansarin M, "Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery", Head Neck, 39(1), pp.71~81 (2017)[DOI]
- Peretti G, "Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers", Head Neck, 38(7), pp.1107~1112 (2016)[DOI]
- Breda E, "Transoral laser microsurgery for laryngeal carcinoma: survival analysis in a hospital-based population", Head Neck, 37(8), pp.1181~1186 (2015)[DOI]
- Pantazis D, "Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery", Eur Arch Otorhinolaryngol, 272(8), pp.1983~1990 (2015)[DOI]
- Vilaseca I, "Transoral laser microsurgery for T3 laryngeal tumors: prognostic factors", Head Neck, 32(7), pp.929~938 (2010)
- Motta G, "CO2 laser surgery in the treatment of glottic cancer", Head Neck, 27(8), pp.733~ (2005)[DOI]
- Hinerman RW, "T3 and T4 true vocal cord squamous carcinomas treated with external beam irradiation: a single institution's 35-year experience", Am J Clin Oncol, 30(2), pp.181~185 (2007)[DOI]
- Murakami R, "Concurrent chemoradiation therapy with low-dose CDDP and UFT for glottic carcinomas: evaluation using the sixth edition of the UICC TNM staging system", Acta Oncol, 45(2), pp.162~167 (2006)[DOI]
- Jorgensen K, "Cancer of the larynx: treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients", Acta Oncol, 41(1), pp.69~76 (2002)[DOI]
- MacKenzie RG, "Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery", Int J Radiat Oncol Biol Phys, 47(1), pp.65~71 (2000)[DOI]
- Mendenhall WM, "Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx", J Clin Oncol, 15(6), pp.2394~2402 (1997)[DOI]
- Wang CC, "Factors influencing the success of radiation therapy for T2 and T3 glottic carcinomas: importance of cord mobility and sex", Am J Clin Oncol, 9(6), pp.517~520 (1986)[DOI]
- Furusaka T, "Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx", Acta Otolaryngol, 133(6), pp.633~640 (2013)[DOI]
- Lin C, "Concurrent chemoradiation for T3 glottic squamous cell carcinoma: a reasonable alternative to upfront laryngectomy", Adv Cancer Res Treat, 2012, pp.461217~ (2012)
- Chen AY, "Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007", Arch Otolaryngol Head Neck Surg, 137(10), pp.1017~1024 (2011)[DOI]
- O'Neill CB, "Treatment complications and survival in advanced laryngeal cancer: a population-based analysis", Laryngoscope, 124(12), pp.2707~2713 (2014)[DOI]
- Laccourreye H, "Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas", Laryngoscope, 100(7), pp.735~741 (1990)
- Al-Gilani M, "Surgical vs nonsurgical treatment modalities for T3 glottic squamous cell carcinoma", JAMA Otolaryngol Head Neck Surg, 142(10), pp.940~946 (2016)[DOI]
- Weinstein GS, "Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy", Laryngoscope, 111(2), pp.191~199 (2001)[DOI]
